United States-based Johnson & Johnson (NYSE: JNJ) announced on Tuesday that it has named Jessica Moore as its new vice president of Investor Relations effective 1 November 2021.
Moore is to report to Joseph Wolk, executive vice president and chief financial officer of the company.
Moore has 20 years of international financial experience covering Sales Operations, Corporate and Regional positions. She has held the position of the vice president and chief financial officer for the Janssen Pharmaceutical business in the EMEA Region and various leadership positions of increasing responsibilities at Baxter International. She holds a bachelor's degree in Finance and Accounting from Miami (of Ohio) University and an MBA from the Kellogg School of Management at Northwestern University.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer